Kelly Blanchard is president of Ibis Reproductive Health.
Her research has included clinical and social science studies on improving contraception and abortion technologies, including medication and surgical abortion, emergency contraception, and oral contraceptives; expanding access to and quality of reproductive health services; and documenting the impact of policies on women’s health around the world.
Kelly has had a range of leadership roles in key HIV-prevention clinical trials evaluating safety and effectiveness of microbicides and the diaphragm in sub-Saharan Africa and Southeast Asia.
She has authored more than 50 peer-reviewed publications in high-impact journals like The Lancet and the American Journal of Public Health, and has also published op-eds, letters, and blogs in The New York Times, the Boston Globe, and RH Reality Check.
Kelly holds a master of science in population and international health and a bachelor of arts in social studies from Harvard University.